The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2022

Filed:

May. 16, 2019
Applicant:

Infex Therapeutics Limited, Macclesfield, GB;

Inventors:

Ian Cooper, Macclesfield, GB;

David Orr, Macclesfield, GB;

Andrew Wilkinson, Macclesfield, GB;

Jonathan Finlayson, Macclesfield, GB;

Adam Bunt, Macclesfield, GB;

Pia Appelqvist, Trosa, SE;

Hans Wallberg, Huddinge, SE;

Fredrik Wångsell, Mölndal, SE;

Assignee:

INFEX Therapeutics Limited, Macclesfield, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 207/48 (2006.01); C07D 403/04 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 487/04 (2006.01); C07D 417/04 (2006.01); A61P 31/04 (2006.01); C07D 207/36 (2006.01);
U.S. Cl.
CPC ...
C07D 207/48 (2013.01); A61P 31/04 (2018.01); C07D 207/36 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 417/04 (2013.01); C07D 487/04 (2013.01);
Abstract

This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-β-lactamase inhibitors.


Find Patent Forward Citations

Loading…